Publications by authors named "Philip Lackey"

Claim this Profile
I
Immunological and virological response to fostemsavir in routine US clinical care: An OPERA cohort study.
Ricky K Hsu, Laurence Brunet, Philip C Lackey, Gerald Pierone, Brooke Levis

HIV Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes.
Ricky K Hsu, Jennifer S Fusco, Cassidy E Henegar, Vani Vannappagari, Andrew Clark, Philip C Lackey

BMC Infect Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core Agents.
Anthony M Mills, Kathy L Schulman, Jennifer S Fusco, Michael B Wohlfeiler, Julie L Priest, Philip C Lackey

Open Forum Infect Dis· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral therapy and liver disorders in the OPERA cohort.
Michael Wohlfeiler, Karam Mounzer, Laurence Brunet, Jennifer Fusco, Vani Vannappagari, Philip Lackey

Ther Adv Drug Saf· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study.
Anthony M Mills, Laurence Brunet, Jennifer S Fusco, Michael B Wohlfeiler, Cindy P Garris, Philip C Lackey

Infect Dis Ther· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice.
Philip Lackey, Anthony Mills, Felix Carpio, Ricky Hsu, Edwin DeJesus

Clin Drug Investig· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment.
Kimberly Y Smith, Parul Patel, Derek Fine, Nicholaos Bellos, Louis Sloan, Philip Lackey

AIDS· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial.
Joseph Eron, Patrick Yeni, Joseph Gathe, Vicente Estrada, Edwin DeJesus, Philip Lackey

Lancet· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis